Ledipasvir and sofosbuvir
Harvoni is a prescription medication by Gilead Sciences containing ledipasvir and sofosbuvir, used to treat chronic hepatitis C virus (HCV) infection in adults. It comes as oral pellets in strengths like 45 mg ledipasvir and 200 mg sofosbuvir per packet, taken once daily for 8-12 weeks depending on HCV genotype. It works by inhibiting HCV replication. Consult a doctor for proper use and side effects. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Harvoni is a prescription medication by Gilead Sciences containing ledipasvir and sofosbuvir, used to treat chronic hepatitis C virus (HCV) infection in adults. It comes as oral pellets in strengths like 45 mg ledipasvir and 200 mg sofosbuvir per packet, taken once daily for 8-12 weeks depending on HCV genotype. It works by inhibiting HCV replication. Consult a doctor for proper use and side effects. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Ledipasvir and sofosbuvir", "mediaType": "text/html", "description": " Access the FDA dataset for Ledipasvir and sofosbuvir — ANDA 212477 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212477" } ] |
| identifier | ANDA212477 |
| issued | 2016-09-16 |
| keyword |
[ "drug-manufacturers", "drug-safety", "health-care", "medications", "prescription-drugs" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Ledipasvir and sofosbuvir |
